FDA Inspection 1096414 — Continental Services Group, Inc.
The FDA completed an inspection of Continental Services Group, Inc. on Jul 9, 2019 in Miami, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 9, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Miami, FL (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 334 | 21 CFR 640.64(e) | Aseptic method of collection, separation and return of RBCs |
| 41 | 21 CFR 606.40(a)(1) | Provide space for examination |